BamSEC and AlphaSense Join Forces
Learn More

Lantern Pharma Inc. – Material Contracts

NASDAQ: LTRN    
Share price (6/29/26): $4.07    
Market cap (6/29/26): $51.9 million

Material Contracts Filter

EX-10.1
from 8-K 47 pages Securities Purchase Agreement
12/34/56
EX-10.18
from 10-K/A 2 pages Fifth Amendment to Employment Agreement
12/34/56
EX-10.17
from 10-K 2 pages Seventh Amendment to Employment Agreement
12/34/56
EX-10.7
from 10-K 2 pages Fourth Amendment to Employment Agreement
12/34/56
EX-10.6
from 10-K 2 pages Fifth Amendment to Employment Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Fourth Amendment to Employment Agreement
12/34/56
EX-10.1
from 10-K 16 pages Second Amended and Restated Lantern Pharma Inc. 2018 Equity Incentive Plan I. General Provisions
12/34/56
EX-10.1
from 10-Q 2 pages Third Amendment to Employment Agreement
12/34/56
EX-10.2
from 10-Q 2 pages Third Amendment to Employment Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Second Amendment to Employment Agreement
12/34/56
EX-10.17
from 10-K 2 pages Amendment to Employment Agreement
12/34/56
EX-10.16
from S-1 9 pages Second Addendum to Technology License Agreement
12/34/56
EX-10.1
from 10-Q 27 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.3
from S-1/A 3 pages Amendment to Employment Agreement
12/34/56
EX-10.16
from S-1/A 15 pages Employment Agreement
12/34/56
EX-10.15
from S-1/A 3 pages Lock-Up Agreement
12/34/56
EX-10.4
from S-1/A 15 pages Employment Agreement
12/34/56
EX-10.3
from S-1/A 3 pages Amendment to Employment Agreement
12/34/56
EX-10.12
from S-1 13 pages Addendum to Technology License Agreement by and Between Af Chemicals LLC and Lantern Pharma, Inc
12/34/56
EX-10.11
from S-1 30 pages Assignment Agreement
12/34/56